Protection Health Care

Bortezomib injection (often indicated as "IP", referring to the Indian Pharmacopoeia standard) is a targeted cancer drug (a proteasome inhibitor) used to treat multiple myeloma and mantle cell lymphoma. It works by interfering with the breakdown of proteins in cancer cells, causing them to die

Infliximab Powder for Concentrate for Solution for Infusion (r-DNA origin) INFiMAB is a monoclonal antibody used to treat autoimmune and inflammatory conditions. It targets and neutralizes tumor necrosis factor-alpha (TNF-α), a key protein involved in inflammation, thereby reducing symptoms and preventing disease progression.

Etanercept Solution for Injection 25 mg/0.5 mL (Intace) is a biologic medication used to treat autoimmune and inflammatory disorders. It is a tumor necrosis factor (TNF) inhibitor that works by blocking the activity of TNF, a protein responsible for inflammation and joint damage.

Denosumab Solution for Injection 60 mg/mL is a monoclonal antibody used to treat bone-related conditions by inhibiting RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), a key protein involved in bone resorption. 

Description:

Bortezomib is a targeted anticancer agent classified as a 26S proteasome inhibitor. It is primarily used in the treatment of multiple myeloma and mantle cell lymphoma (MCL).

Each vial contains:

• Bortezomib IP – 2.5 mg (as a sterile lyophilized powder)

• Excipients – Mannitol or other stabilizers (varies by brand)

The powder must be reconstituted before administration.

Description:

Azacitidine is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug. It belongs to the class of nucleoside metabolic inhibitors, specifically a pyrimidine nucleoside analogue of cytidine.

Description:

Bortezomib is a reversible proteasome inhibitor used in the treatment of multiple myeloma and mantle cell lymphoma. It disrupts normal protein degradation within cells, leading to cancer cell death.

Each vial contains:

• Bortezomib IP – 2 mg (as a sterile, lyophilized powder)

• Excipients: Mannitol or other stabilizers (varies by manufacturer)

• Must be reconstituted with normal saline (0.9% NaCl) prior to use

Triptorelin Acetate, sold under the brand name Decapeptyl, is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) agonists. It is used to treat hormone-sensitive conditions such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty, and is also used in fertility treatments like IVF. The 0.1 mg injection is a short-acting formulation typically given daily under the skin (subcutaneously) or into the muscle (intramuscularly). Triptorelin works by initially stimulating, then significantly suppressing the production of sex hormones like testosterone and estrogen by acting on the pituitary gland. This hormonal suppression helps in controlling the progression of hormone-dependent conditions. Common side effects may include hot flashes, mood changes, headaches, and reduced libido. Long-term use may also lead to bone thinning, so regular medical monitoring is essential. This medication should only be used under the supervision of a healthcare professional.

Nimotuzumab Injection (Biomab EGFR) is a humanized monoclonal antibody used in the treatment of various cancers, particularly those associated with overexpression of the Epidermal Growth Factor Receptor (EGFR).

Ranibizumab Solution for Injection 10 mg/mL Vial 2 is a recombinant humanized monoclonal antibody fragment used to treat eye disorders caused by abnormal blood vessel growth and leakage

Trastuzumab Lyophilized Powder for Concentrate for Solution for Infusion is a monoclonal antibody used to treat HER2-positive breast and gastric cancers. It specifically targets the human epidermal growth factor receptor 2 (HER2), a protein that promotes the growth of cancer cells. By binding to HER2, trastuzumab inhibits tumor cell proliferation and mediates immune system attacks on cancer cells. 

Ofatumumab 300 mg Concentrate for Solution for Infusion

Generic name: Ofatumumab
Dosage form: Concentrate for solution for infusion
Strength: 300 mg/60 mL (5 mg/mL)
Route of administration: Intravenous infusion

Pertuzumab Injection 420 mg/14 mL is a recombinant humanized monoclonal antibody used in the treatment of HER2-positive breast cancer. It works by specifically targeting the HER2 receptor on cancer cells, blocking signals that promote cell growth and survival, and enhancing the body’s immune response to destroy these cells

Gemcitabine is a nucleoside analog used as a cytotoxic (anticancer) agent. It is a pyrimidine antimetabolite structurally related to cytarabine. Gemcitabine must be reconstituted and administered intravenously under the supervision of a qualified healthcare professional.

Erythropoietin Injection I.P. 10000 IU/ml (Epofer 10000) is a recombinant human erythropoietin formulation used to treat anemia caused by chronic kidney disease, chemotherapy, or other medical conditions leading to low red blood cell production.

Erythropoietin Injection I.P. 4000 IU/ml (Epofer 4000) is a therapeutic formulation used to treat anemia, particularly in patients with chronic kidney disease, those undergoing dialysis, or cancer patients receiving chemotherapy.

Fulvestrant Injection B.P. 5 mL (50 mg/mL) is an estrogen receptor antagonist used in the treatment of hormone receptor-positive advanced or metastatic breast cancer in postmenopausal women.

Denosumab Solution for Injection (Esentra 120) is a monoclonal antibody used to treat bone-related disorders by inhibiting RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), a key protein responsible for bone resorption.

Pertuzumab Injection (Perjeta®) is a recombinant humanized monoclonal antibody used in the treatment of HER2-positive breast cancer. It works by specifically binding to the HER2 receptor on cancer cells, blocking signaling pathways that promote tumor growth and survival, and enhancing immune-mediated destruction of these cells. 

Human Normal Albumin Injection is a sterile preparation of albumin obtained from screened human plasma. It is used to restore and maintain blood volume and plasma oncotic pressure in conditions such as hypovolemia, shock, burns, hypoalbuminemia, liver cirrhosis with ascites, and nephrotic syndrome. The injection works by drawing fluid from the interstitial spaces back into the blood circulation, thereby improving circulatory volume and tissue perfusion. It is usually administered intravenously under medical supervision, with the dose and rate adjusted according to the patient’s clinical condition. Possible side effects include fever, chills, allergic reactions, and fluid overload if given rapidly.

Carfilzomib for Injection (Carfican) is a proteasome inhibitor used in the treatment of multiple myeloma, a type of blood cancer.

Irinotecan Hydrochloride Injection 40 mg is a chemotherapy medication used primarily to treat metastatic cancer of the colon and rectum. It works by stopping or slowing the growth of cancer cells and is administered by a healthcare professional as an intravenous (IV) infusion